Genetron Health to Announce First Quarter 2022 Unaudited Financial Results and Host Investor Call on June 2, 2022
BEIJING, May 23, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced that it will report unaudited financial results for the first quarter ended March 31, 2022 on June 2, 2022 before the US market open.
Management will host a conference call for investors at 8:30 a.m. ET (8:30 p.m. Beijing time) on Thursday, June 2, 2022. The conference call can be accessed by dialing the following numbers:
Participants are encouraged to dial into the call at least 15 minutes in advance due to high call volumes.
A simultaneous webcast of the conference call will be available on the "Events and Presentations" page of the Investors section of the Company's website. A replay of the webcast will e available for 30 days following the event. For more information, please visit ir.genetronhealth.com.
About Genetron Holdings Limited
Safe Harbor Statement
Investor Relations Contact
Philip Trip Taylor